Method of detecting breast cancer genetic probes

Recently, the Jefferson Medical College researchers have used precise radiolabelled DNA probe on mouse cancer gene activity was detected in vitro. This probe with an active cancer genes from the genetic code copy of adhesion to work. Such probes may be in the near future to help doctors and researchers to detect cancer and determine the appropriate treatment.

In 2008, in the United States will have about 40,000 women die, and almost half occurred in women who are 40 years of age, about a quarter of patients aged 40 to 49 years of age. Women aged over 50 accounted for only one-fifth of patients.

The researchers had hoped that as soon as possible to detect cancerous breast tumors, especially in the beginning of their spread to other parts of the body before. The new study, researchers attempt to ascertain whether the activities of oncogene status of cyclinD1 be able to tell doctors the most appropriate method of treatment.

Already know, cyclinD1 gene in the majority of both was thrown open. DNA probes used in the study of radioactive label and can carry the mRNA with the combination of cyclinD1, while the mRNA is translated with the DNA instructions and protein synthesis are closely linked.

Dr. WickstromMathewThakur people think that the use of genetic probes to cancer gene activity in the detection of a visual strategy in other types of cancer to other cancer gene activity is also equally effective.

Dr. Wickstrom to predict the specific test for cyclinD1 will eventually be used by medical institutions. By that time, in addition to the breast X-ray photograph, women can also be used to detect genetic probes to find a suspicious lump. Such probes can also be used to detect pre-cancerous area. Moreover, the patient will be able to determine by in vitro detection of cancer gene activity is thus avoiding the use of surgery necessary.